Market Overview

My goal is to be on stage with my computer and let you
see my screen and make sure you know what buttons to
press, where you’re getting in & out, how to calculate
risk, your targets — all of those things.
It’s real-life trading. Make sure you sign up!
- Jerremy Newsome
GET TICKETS

Biotech Sector Weak Headed Into Year's End

Share:
Biotech Sector Weak Headed Into Year's End

Biotech investors can’t seem to get any relief from the selling pressure that has plagued the sector throughout 2016. Heading into the last few trading days of the year, biotech stocks appear to be closing 2016 on a low note.

Biotech stocks are having another tough day Thursday. In the past five trading sessions, the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB) is down 2.0 percent and the SPDR S&P Biotech (ETF) (NYSE: XBI) is down 3.6 percent.

The move has been even more exaggerated in levered biotech ETFs. The Direxion Daily S&P Biotech Bull 3X Shares (NYSE: LABU) is down 10.4 percent, while the Direxion Daily S&P Biotech Bear 3X Shares (NYSE: LABD) is up 10.6 percent.

Run-Up To The Election, Then A Slide

Biotech stocks initially got a big boost when Donald Trump prevailed on Election Day. However, in a December interview with Time, Trump definitively said, “I’m going to bring down drug prices.” That statement rattled biotech stocks, which have since failed to recover.

Rising interest rates may also be weighing on the sector as well.

However, biotech weakness in the closing days of the year may also be driven by tax loss selling. With the S&P 500 up more than 10 percent in 2016, many traders may be looking to offset capital gains by selling some of their worst-performing stocks for tax purposes.

Year-to-date, the IBB ETF is down 21.1 percent.

Posted-In: Biotech Sector ETFs Politics Movers Trading Ideas ETFs General Best of Benzinga

 

Related Articles (IBB + LABD)

View Comments and Join the Discussion!
Lightning Fast
Market News Service
$199 Free 14 Day Trial

RBC's 3 Restaurant Picks For 2017

12 Biggest Mid-Day Losers For Thursday